THERMO FISHER SCIENTIFIC INC's ticker is TMO and the CUSIP is 883556102. A total of 2,355 filers reported holding THERMO FISHER SCIENTIFIC INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.8%.
About THERMO FISHER SCIENTIFIC INC
Thermo Fisher Scientific Inc. is a leading company in the field of scientific research and laboratory equipment. The company provides a wide range of products and services to customers in the life sciences, healthcare, and industrial markets. Thermo Fisher Scientific Inc. has a strong reputation for quality and innovation, and is known for its commitment to customer satisfaction.
The company's product portfolio includes laboratory equipment, reagents, chemicals, and software. Thermo Fisher Scientific Inc. also offers a range of services, including laboratory outsourcing, clinical trials management, and scientific consulting. The company's products and services are used by researchers, scientists, and healthcare professionals around the world.
Thermo Fisher Scientific Inc. has a strong financial position, with a market capitalization of over $200 billion. The company has a solid track record of revenue growth and profitability, and has consistently delivered strong financial results to its shareholders.
The company's management team is led by CEO Marc N. Casper, who has been with the company since 2001. Under his leadership, Thermo Fisher Scientific Inc. has grown into a global leader in the scientific research and laboratory equipment industry.
In conclusion, Thermo Fisher Scientific Inc. is a highly respected company in the scientific research and laboratory equipment industry. With a strong product portfolio, a commitment to customer satisfaction, and a solid financial position, the company is well positioned for continued success in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,800,015 | -12.2% | 3,255 | -7.7% | 0.50% | +1.8% |
| Q1 2024 | $2,050,509 | +4.2% | 3,528 | -4.8% | 0.49% | +4.2% |
| Q4 2023 | $1,967,108 | +9.1% | 3,706 | +4.0% | 0.47% | +1.5% |
| Q3 2023 | $1,802,978 | -10.0% | 3,562 | -7.2% | 0.46% | -12.9% |
| Q2 2023 | $2,002,998 | -4.6% | 3,839 | +5.4% | 0.53% | -23.1% |
| Q1 2023 | $2,100,292 | +2.0% | 3,644 | -2.5% | 0.69% | -5.7% |
| Q4 2022 | $2,058,479 | +14.7% | 3,738 | +5.7% | 0.74% | +5.6% |
| Q3 2022 | $1,794,000 | -16.0% | 3,537 | -10.0% | 0.70% | -8.0% |
| Q2 2022 | $2,136,000 | +34.2% | 3,931 | +45.8% | 0.76% | +19.4% |
| Q1 2022 | $1,592,000 | -35.3% | 2,696 | -26.9% | 0.64% | +9.1% |
| Q4 2021 | $2,459,000 | +440.4% | 3,686 | +362.5% | 0.58% | +240.4% |
| Q3 2021 | $455,000 | -78.3% | 797 | -80.8% | 0.17% | -73.2% |
| Q2 2021 | $2,092,000 | -14.4% | 4,147 | -22.6% | 0.64% | -26.7% |
| Q1 2021 | $2,445,000 | – | 5,358 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MIROVA | 215,021 | $124,972,355 | 22.14% |
| Cavalry Management Group, LLC | 2,211 | $81,729,789 | 11.28% |
| Coalescence Partners Investment Management, LP | 23,706 | $13,778,164 | 10.89% |
| Cryder Capital Partners LLP | 422,662 | $245,655,381 | 10.68% |
| Atalan Capital Partners, LP | 203,000 | $117,985,630 | 9.75% |
| Bluegrass Capital Partners LP | 16,000 | $9,299,360 | 9.69% |
| Svenska Handelsbanken AB (publ) | 50,000 | $29,060 | 9.16% |
| RIT CAPITAL PARTNERS PLC | 88,500 | $51,383,985 | 9.14% |
| BlueSpruce Investments, LP | 843,245 | $490,102,426 | 8.76% |
| Stockbridge Partners LLC | 704,422 | $409,417,111 | 8.44% |